Position in RVMD
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$842,760
New position
Shares Held
4,500
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#386
of 687 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Guardian Partners Inc. holds $5,886,181 across 6 Biotechnology names. RVMD ranks #2 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABCL |
AbCellera Biologics Inc.
|
595,998 | $4,678,584 | |
| 2 | RVMD |
Revolution Medicines, Inc.
This page
|
4,500 | $842,760 | |
| 3 | ABVX |
Abivax S.A.
|
2,700 | $359,802 | |
| 4 | DFTX |
Definium Therapeutics, Inc.
|
66 | $3,104 | |
| 5 | ATAI |
AtaiBeckley Inc.
|
295 | $1,554 | |
| 6 | SRPT |
Sarepta Therapeutics, Inc.
|
21 | $377 |
All Filings in RVMD
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $842,760 | 4,500 | Shares | Sole | 2026-07-29 | |
| No filing history on record for this holder in this stock. | ||||||